A/C Enzymatic Homocysteine Assay
Urinary Homocystine (Nonquantitative) Test System. 510(k) K030754, from Anticancer, Inc. (San Diego, CA). Product code LPS, class 2.
As of Nov 20, 2026, K030754 is an FDA 510(k) held by Anticancer, Inc., substantially equivalent on Jul 11, 2003 after 123 days, with no recalls tied to it in FDA's recall database.
- Review time: 123 days
- Recalls: 0
- Cited as a predicate by: 1 device
The A/C Enzymatic Homocysteine Assay is intended for the quantitative determination of total homocysteine (tHCY) in human plasma or serum. - The device can assist in the diagnosis and treatment of patients suspected of having hyperhomocysteinemia. - The A/C Enzymatic Homocysteine Assay is only for in vitro diagnostic use. Preservation Use
- Bio-Rad Homocysteine BY HplcK993107 · Bio-Rad · Dec 21, 1999
- A/C Portable Enzymatic Homocysteine AssayK080851 · Anticancer, Inc. · Oct 10, 2008
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 10, 2003
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1377
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files